ZKOPH

Zhaoke Ophthalmology Receives Good Manufacturing Practice (GMP) Certification from Australia's Therapeutic Goods Administration

read

2026-10-27

National Toxicology Conference | Zhaoke Ophthalmology Presents Its Self-Developed Model of Diabetes-Related Retinal Injury to Advance Translational Pharmacology Research

read

2026-10-20

243

Zhaoke Ophthalmology Showcases at CPHI Europe 2026, Actively Advancing Overseas Collaboration for Innovative Ophthalmic Products

read

2026-10-10

428

Zhaoke Ophthalmology's Presbyopia Drug YUVEZZI™ Met the Primary Endpoint in its Phase II Trial in China

read

2026-09-04

1165

Zhaoke Ophthalmology Announces 2026 Interim Results

read

2026-08-28

1797

首页 1 2 3 4 5 尾页

Guangzhou Headquarters

Tel: 020-39062828

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

粤公网安备 44011502000975号

粤ICP备2022095718号

Wechat

Guangzhou Headquarters

Tel: 020-39062888

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

粤公网安备 44011502000975号

粤ICP备2022095718号

Wechat